{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:03:39Z","timestamp":1791259419781,"version":"4.1.0"},"reference-count":70,"publisher":"American Psychiatric Association Publishing","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2000,7,1]]},"DOI":"10.1176\/appi.ajp.157.7.1141","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:10:43Z","timestamp":1034359843000},"page":"1141-1149","source":"Crossref","is-referenced-by-count":324,"title":["Ionotropic Glutamate Receptors and Expression of <i>N<\/i>-Methyl-<scp>d<\/scp>-Aspartate Receptor Subunits in Subregions of Human Hippocampus: Effects of Schizophrenia"],"prefix":"10.1176","volume":"157","author":[{"given":"Xue-Min","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinda C.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"Conley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Tamminga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1577BABBJJEH","doi-asserted-by":"crossref","unstructured":"Bogerts B, Ashtari M, Degreef G, Alvir JM, Bilder RM, Lieberman JA: Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res 1990; 35:1\u201313","DOI":"10.1016\/0925-4927(90)90004-P"},{"key":"atypb1","doi-asserted-by":"crossref","unstructured":"Bogerts B, Falkai P, Haupts M, Greve B, Ernst S, Tapernon-Franz U, Heinzmann U: Post-mortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics: initial results from a new brain collection. Schizophr Res 1990; 3:295\u2013301","DOI":"10.1016\/0920-9964(90)90013-W"},{"key":"atypb2","doi-asserted-by":"crossref","unstructured":"Becker T, Elmer K, Schneider F, Schneider M, Grodd W, Bartels M, Heckers S, Beckmann H: Confirmation of reduced temporal limbic structure volume on magnetic resonance imaging in male patients with schizophrenia. Psychiatry Res 1996; 67:135\u2013143","DOI":"10.1016\/0925-4927(96)03002-8"},{"key":"atypb3","doi-asserted-by":"crossref","unstructured":"Bilder RM, Bogerts B, Ashtari M, Wu H, Alvir JM, Jody D, Reiter G, Bell L, Lieberman JA: Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia. Schizophr Res 1995; 17:47\u201358","DOI":"10.1016\/0920-9964(95)00028-K"},{"key":"R1577BABDGBBF","doi-asserted-by":"crossref","unstructured":"Suddath RL, Casanova MF, Goldberg TE, Daniel DG, Kelsoe JR Jr, Weinberger DR: Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study. Am J Psychiatry 1989; 146:464\u2013472","DOI":"10.1176\/ajp.146.4.464"},{"key":"R1577BABEDIIA","unstructured":"Kovelman JA, Scheibel AB: A neurohistological correlate of schizophrenia. Biol Psychiatry 1984; 19:1601\u20131621"},{"key":"atypb4","doi-asserted-by":"crossref","unstructured":"Heckers S, Heinsen H, Geiger B, Beckmann H: Hippocampal neuron number in schizophrenia. Arch Gen Psychiatry 1991; 48:1002\u20131008","DOI":"10.1001\/archpsyc.1991.01810350042006"},{"key":"atypb5","doi-asserted-by":"crossref","unstructured":"Jeste DV, Lohr JB: Hippocampal pathologic findings in schizophrenia: a morphometric study. Arch Gen Psychiatry 1989; 46:1019\u20131024","DOI":"10.1001\/archpsyc.1989.01810110061009"},{"key":"atypb6","doi-asserted-by":"crossref","unstructured":"Falkai P, Bogerts B: Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci 1986; 236:154\u2013161","DOI":"10.1007\/BF00380943"},{"key":"atypb7","doi-asserted-by":"crossref","unstructured":"Benes FM, Kwok EW, Vincent SL, Todtenkopf MS: A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 1998; 44:88\u201397","DOI":"10.1016\/S0006-3223(98)00138-3"},{"key":"R1577BABIDBFJ","doi-asserted-by":"crossref","unstructured":"Benes FM, Sorensen I, Bird ED: Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophr Bull 1991; 17:597\u2013608","DOI":"10.1093\/schbul\/17.4.597"},{"key":"R1577BABBJDIF","doi-asserted-by":"crossref","unstructured":"Altshuler LL, Casanova MF, Goldberg TE, Kleinman JE: The hippocampus and para-hippocampus in schizophrenic, suicide, and control brains. Arch Gen Psychiatry 1990; 47:1029\u20131034","DOI":"10.1001\/archpsyc.1990.01810230045008"},{"key":"R1577BABCJAAB","doi-asserted-by":"crossref","unstructured":"Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN, Carpenter WT: Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 1992; 49:522\u2013530","DOI":"10.1001\/archpsyc.1992.01820070016003"},{"key":"atypb8","doi-asserted-by":"crossref","unstructured":"Nordahl TE, Kusubov N, Carter C, Salamat S, Cummings AM, O\u2019Shora-Celaya L, Eberling J, Robertson L, Huesman RH, Jagust W, Budinger TF: Temporal lobe metabolic differences in medication-free outpatients with schizophrenia via the PET-600. Neuropsychopharmacology 1996; 15:541\u2013554","DOI":"10.1016\/S0893-133X(96)00098-X"},{"key":"atypb9","doi-asserted-by":"crossref","unstructured":"Haznedar MM, Buchsbaum MS, Luu C, Hazlett EA, Siegel BV Jr, Lohr J, Wu J, Haier RJ, Bunney WE Jr: Decreased anterior cingulate gyrus metabolic rate in schizophrenia. Am J Psychiatry 1997; 154:682\u2013684","DOI":"10.1176\/ajp.154.5.682"},{"key":"atypb10","doi-asserted-by":"crossref","unstructured":"Heckers S, Rauch SL, Goff D, Savage CR, Schacter DL, Fischman AJ, Alpert NM: Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat Neurosci 1998; 1:318\u2013323","DOI":"10.1038\/1137"},{"key":"R1577BABBFIEG","doi-asserted-by":"crossref","unstructured":"Fletcher P: The missing link: a failure of fronto-hippocampal integration in schizophrenia (comment). Nat Neurosci 1998; 1:266\u2013267","DOI":"10.1038\/1078"},{"key":"R1577BABIDBIE","doi-asserted-by":"crossref","unstructured":"Gruzelier J, Seymour K, Wilson L, Jolley A, Hirsch S: Impairments on neuropsychologic tests of temporohippocampal and frontohippocampal functions and word fluency in remitting schizophrenia and affective disorders. Arch Gen Psychiatry 1988; 45:623\u2013629","DOI":"10.1001\/archpsyc.1988.01800310027003"},{"key":"atypb11","doi-asserted-by":"crossref","unstructured":"Venables PH: Hippocampal function and schizophrenia: experimental psychological evidence. Ann NY Acad Sci 1992; 658:111\u2013127","DOI":"10.1111\/j.1749-6632.1992.tb22841.x"},{"key":"R1577BABJBBCH","doi-asserted-by":"crossref","unstructured":"Green MF: What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 1996; 153:321\u2013330","DOI":"10.1176\/ajp.153.3.321"},{"key":"R1577BABBBCFH","doi-asserted-by":"crossref","unstructured":"Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R: Study of a new schizophrenomimetic drug: serenyl. Arch Neurol Psychiatry 1959; 71:363\u2013369","DOI":"10.1001\/archneurpsyc.1959.02340150095011"},{"key":"R1577BABCACAF","doi-asserted-by":"crossref","unstructured":"Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner D, Heninger GR, Bowers MB, Charney DS: Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994; 51:199\u2013214","DOI":"10.1001\/archpsyc.1994.03950030035004"},{"key":"R1577BABFCEEC","unstructured":"Pearlson GD: Psychiatric and medical syndromes associated with phencyclidine (PCP) abuse. Johns Hopkins Med J 1981; 148:25\u201333"},{"key":"R1577BABBGACI","doi-asserted-by":"crossref","unstructured":"Lahti AC, Koffel B, LaPorte D, Tamminga CA: Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 1995; 13:9\u201319","DOI":"10.1038\/sj.npp.1380271"},{"key":"R1577BABHIGJH","doi-asserted-by":"crossref","unstructured":"Tamminga CA: Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol 1998; 12:21\u201336","DOI":"10.1615\/CritRevNeurobiol.v12.i1-2.20"},{"key":"R1577BABIAIIF","doi-asserted-by":"crossref","unstructured":"Gao XM, Shirakawa O, Du F, Tamminga CA: Delayed regional metabolic actions of phencyclidine. Eur J Pharmacol 1993; 241:7\u201315","DOI":"10.1016\/0014-2999(93)90926-9"},{"key":"R1577BABDHECF","doi-asserted-by":"crossref","unstructured":"Gao XM, Hashimoto T, Tamminga CA: Phencyclidine (PCP) and dizocilpine (MK801) exert time-dependent effects on the expression of immediate early genes in rat brain. Synapse 1998; 29:14\u201328","DOI":"10.1002\/(SICI)1098-2396(199805)29:1<14::AID-SYN2>3.0.CO;2-E"},{"key":"R1577BABJICJC","doi-asserted-by":"crossref","unstructured":"Gao XM, Tamminga CA: MK801 induces late regional increases in NMDA and kainate receptor binding in rat brain. J Neural Transm Gen Sect 1995; 101:105\u2013113","DOI":"10.1007\/BF01271549"},{"key":"R1577BABIJFAH","doi-asserted-by":"crossref","unstructured":"Gao XM, Tamminga CA: Phencyclidine produces changes in NMDA and kainate receptor binding in rat hippocampus over a 48-hour time course. Synapse 1996; 23:274\u2013279","DOI":"10.1002\/(SICI)1098-2396(199608)23:4<274::AID-SYN5>3.0.CO;2-4"},{"key":"R1577BABIGAHF","doi-asserted-by":"crossref","unstructured":"Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE, Coyle JT: Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 1995; 52:829\u2013836","DOI":"10.1001\/archpsyc.1995.03950220039008"},{"key":"R1577BABBACIF","doi-asserted-by":"crossref","unstructured":"Kingsbury AE, Foster OJ, Nisbet AP, Cairns N, Bray L, Eve DJ, Lees AJ, Marsden CD: Tissue pH as an indicator of mRNA preservation in human postmortem brain. Brain Res Mol Brain Res 1995; 28:311\u2013318","DOI":"10.1016\/0169-328X(94)00219-5"},{"key":"R1577BABIJCGE","doi-asserted-by":"crossref","unstructured":"Hill C, Keks NA, Roberts S, Opeskin K, Dean B, MacKinnon A, Copolov D: Problem of diagnosis in postmortem brain studies of schizophrenia. Am J Psychiatry 1996; 153:533\u2013537","DOI":"10.1176\/ajp.153.4.533"},{"key":"R1577BABFCACG","unstructured":"Foster P: Neuroleptic equivalence. Pharmaceutical J 1998; 243:431\u2013432"},{"key":"R1577BABEDHHD","doi-asserted-by":"crossref","unstructured":"Gao XM, Hashimoto T, Cooper TB, Tamminga CA: The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration. J Neural Transm 1997; 104:97\u2013104","DOI":"10.1007\/BF01271298"},{"key":"R1577BABHJEBH","doi-asserted-by":"crossref","unstructured":"Bockers TM, Zimmer M, Muller A, Bergmann M, Brose N, Kreutz MR: Expression of the NMDA R1 in selected human brain regions. Neuroreport 1994; 5:965\u2013969","DOI":"10.1097\/00001756-199404000-00028"},{"key":"R1577BABHGIEC","doi-asserted-by":"crossref","unstructured":"Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH: Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994; 12:529\u2013540","DOI":"10.1016\/0896-6273(94)90210-0"},{"key":"R1577BABCJGHE","doi-asserted-by":"crossref","unstructured":"Gao XM, Tamminga CA: An increase in NMDA-sensitive [ 3H]glutamate and [3H]kainate binding in hippocampus 24 hours after PCP. Neurosci Lett 1994; 174:149\u2013153","DOI":"10.1016\/0304-3940(94)90008-6"},{"key":"R1577BABCAACA","doi-asserted-by":"crossref","unstructured":"Kerwin RW, Patel S, Meldrum B, Czudek C, Reynolds GP: Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia. Lancet 1988; 1:583\u2013584","DOI":"10.1016\/S0140-6736(88)91371-2"},{"key":"R1577BABBFJCE","doi-asserted-by":"crossref","unstructured":"Kerwin R, Patel S, Meldrum B: Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain postmortem. Neuroscience 1990; 39:25\u201332","DOI":"10.1016\/0306-4522(90)90219-T"},{"key":"R1577BABBHIIB","doi-asserted-by":"crossref","unstructured":"Stevens JR: An anatomy of schizophrenia? Arch Gen Psychiatry 1973; 29:177\u2013189","DOI":"10.1001\/archpsyc.1973.04200020023003"},{"key":"R1577BABGIAIE","doi-asserted-by":"crossref","unstructured":"Gray JA: Dopamine release in the nucleus accumbens: the perspective from aberrations of consciousness in schizophrenia. Neuropsychologia 1995; 33:1143\u20131153","DOI":"10.1016\/0028-3932(95)00054-7"},{"key":"R1577BABIICBD","doi-asserted-by":"crossref","unstructured":"Javitt DC, Zukin SR: The role of excitatory amino acids in neuropsychiatric illness. J Neuropsychiatry Clin Neurosci 1990; 2:44\u201352","DOI":"10.1176\/jnp.2.1.44"},{"key":"R1577BABIEDGH","doi-asserted-by":"crossref","unstructured":"Kornhuber J, Mack-Burkhardt F, Riederer P, Hebenstreit GF, Reynolds GP, Andrews HB, Beckmann H: [3H] MK-801 binding items in postmortem brain regions of schizophrenic patients. J Neural Transm 1989; 77:231\u2013236","DOI":"10.1007\/BF01248936"},{"key":"R1577BABBAJDE","doi-asserted-by":"crossref","unstructured":"Ishimaru M, Kurumaji A, Toru M: NMDA-associated glycine binding site increases in schizophrenic brains (letter). Biol Psychiatry 1992; 32:379\u2013381","DOI":"10.1016\/0006-3223(92)90043-Y"},{"key":"R1577BABDGGAJ","doi-asserted-by":"crossref","unstructured":"Simpson MD, Slater P, Royston MC, Deakin JF: Regionally selective deficits in uptake sites for glutamate and gamma-aminobutyric acid in the basal ganglia in schizophrenia. Psychiatry Res 1992; 42:273\u2013282","DOI":"10.1016\/0165-1781(92)90119-N"},{"key":"R1577BABIIACF","doi-asserted-by":"crossref","unstructured":"Deakin JF, Slater P, Simpson MD, Gilchrist AC, Skan WJ, Royston MC, Reynolds GP, Cross AJ: Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J Neurochem 1989; 52:1781\u20131786","DOI":"10.1111\/j.1471-4159.1989.tb07257.x"},{"key":"R1577BABDGGEI","doi-asserted-by":"crossref","unstructured":"Harrison PJ, Kerwin RW, McLaughlin D: Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet 1991; 337:450\u2013452","DOI":"10.1016\/0140-6736(91)93392-M"},{"key":"R1577BABCACJH","doi-asserted-by":"crossref","unstructured":"Porter RH, Eastwood SL, Harrison PJ: Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex, and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia. Brain Res 1997; 751:217\u2013231","DOI":"10.1016\/S0006-8993(96)01404-7"},{"key":"R1577BABFCJCA","doi-asserted-by":"crossref","unstructured":"Eastwood SL, Burnet PW, Harrison PJ: GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: a reverse transcriptase-polymerase chain reaction (RT-PCR) study. Brain Res Mol Brain Res 1997; 44:92\u201398","DOI":"10.1016\/S0169-328X(96)00195-7"},{"key":"R1577BABGGJGB","doi-asserted-by":"crossref","unstructured":"Breese CR, Freedman R, Leonard SS: Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers. Brain Res 1995; 674:82\u201390","DOI":"10.1016\/0006-8993(94)01384-T"},{"key":"R1577BABIGIHC","doi-asserted-by":"crossref","unstructured":"Reynolds, Czudek C, Andrews HB: Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia. Biol Psychiatry 1990; 27:1038\u20131044","DOI":"10.1016\/0006-3223(90)90039-5"},{"key":"R1577BABBEIHF","doi-asserted-by":"crossref","unstructured":"Grimwood S, Slater P, Deakin JFW, Hutson PH: NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia. Neuroreport 1999; 10:461\u2013465","DOI":"10.1097\/00001756-199902250-00004"},{"key":"R1577BABHEEHA","doi-asserted-by":"crossref","unstructured":"Eastwood SL, Harrison PJ: Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography. Neuroscience 1995; 69:339\u2013343","DOI":"10.1016\/0306-4522(95)00324-C"},{"key":"R1577BABCFFBA","doi-asserted-by":"crossref","unstructured":"Kutay FZ, Pogun S, Hariri NI, Peker G, Erlacin S: Free amino acid level determinations in normal and schizophrenic brain. Prog Neuropsychopharmacol Biol Psychiatry 1989; 13:119\u2013126","DOI":"10.1016\/0278-5846(89)90008-0"},{"key":"R1577BABBHGFE","doi-asserted-by":"crossref","unstructured":"Sherman AD, Hegwood TS, Baruah S, Waziri R: Deficient NMDA-mediated glutamate release from synaptosomes of schizophrenics. Biol Psychiatry 1991; 30:1191\u20131198","DOI":"10.1016\/0006-3223(91)90155-F"},{"key":"R1577BABGBJGE","doi-asserted-by":"crossref","unstructured":"Simpson MDC, Slater P, Deakin JFW, Royston MC, Skan WJ: Reduced GABA uptake sites in the temporal lobe in schizophrenia. Neurosci Lett 1989; 107:211\u2013215","DOI":"10.1016\/0304-3940(89)90819-7"},{"key":"R1577BABBHEBJ","doi-asserted-by":"crossref","unstructured":"Zaidel DW, Esiri MM, Harrison PJ: The hippocampus in schizophrenia: lateralized increase in neuronal density and altered cytoarchitectural asymmetry. Psychol Med 1997; 27:703\u2013713","DOI":"10.1017\/S0033291796004618"},{"key":"R1577BABHIBDG","doi-asserted-by":"crossref","unstructured":"Wolosker H, Blackshaw S, Snyder SII: Serine racemase: a glial enzyme synthesizing d-serine to regulate glutamate-N-methyl-d-aspartate neurotransmission. Proc Natl Acad Sci USA 1999; 96:13409\u201313414","DOI":"10.1073\/pnas.96.23.13409"},{"key":"R1577BABGHBHH","doi-asserted-by":"crossref","unstructured":"Csernansky JG, Joshi S, Wang L, Haller JW, Gado M, Miller JP, Grenander U, Miller MI: Hippocampal morphometry in schizophrenia by high dimensional brain mapping. Proc Natl Acad Sci USA 1998; 95:11406\u201311411","DOI":"10.1073\/pnas.95.19.11406"},{"key":"R1577BABEAEDF","unstructured":"Tanaka M, Caudle RM, Benoliel R, Finegold AA, Iadorola MJ: Cellular neuroanatomy of NMDA NR1 splice variants. Abstracts of the Society for Neuroscience 1998; 24:340"},{"key":"atypb12","doi-asserted-by":"crossref","unstructured":"Brimecombe JC, Boeckman FA, Aizenman E: Functional consequences of NR2 subunit composition in single recombinant N-methyl-d-aspartate receptors. Proc Natl Acad Sci USA 1997; 94:11019\u201311024","DOI":"10.1073\/pnas.94.20.11019"},{"key":"R1577BABGJCGH","doi-asserted-by":"crossref","unstructured":"Grant ER, Bacskai BJ, Anegawa NJ, Pleasure DE, Lynch DR: Opposing contributions of NR1 and NR2 to protein kinase C modulation of NMDA receptors. J Neurochem 1998; 71:1471\u20131481","DOI":"10.1046\/j.1471-4159.1998.71041471.x"},{"key":"R1577BABBIDCF","doi-asserted-by":"crossref","unstructured":"Riley BP, Tahir E, Rajagopalan S, Mogudi-Carter M, Faure S, Weissenbach J, Jenkins T, Williamson R: A linkage study of the N-methyl-d-aspartate receptor subunit gene loci and schizophrenia in southern African Bantu-speaking families. Psychiatr Genet 1997; 7:57\u201374","DOI":"10.1097\/00041444-199722000-00002"},{"key":"R1577BABJEJHF","doi-asserted-by":"crossref","unstructured":"Roberts EB, Meredith MA, Ramoa AS: Suppression of NMDA receptor function using antisense DNA block ocular dominance plasticity while preserving visual responses. J Neurophysiol 1998; 80:1021\u20131032","DOI":"10.1152\/jn.1998.80.3.1021"},{"key":"R1577BABDHBFD","doi-asserted-by":"crossref","unstructured":"Kammesheidt A, Kato K, Ito K, Sumikawa K: Adenovirus-mediated NMDA receptor knockouts in the rat hippocampal CA1 region. Neuroreport 1997; 8:635\u2013638","DOI":"10.1097\/00001756-199702100-00011"},{"key":"R1577BABFGEBB","doi-asserted-by":"crossref","unstructured":"Tsien JZ, Chen DF, Gerber D, Tom C, Mercer EH, Anderson DJ, Mayford M, Kandel ER, Tonegawa S: Subregion- and cell type-restricted gene knockout in mouse brain. Cell 1996; 87:1317\u20131326","DOI":"10.1016\/S0092-8674(00)81826-7"},{"key":"R1577BABIHJEE","doi-asserted-by":"crossref","unstructured":"McHugh TJ, Blum KI, Tsien JZ, Tonegawa S, Wilson MA: Impaired hippocampal representation of space in CA1-specific NMDA R1 knockout mice. Cell 1996; 87:1339\u20131349","DOI":"10.1016\/S0092-8674(00)81828-0"},{"key":"R1577BABDHHAB","doi-asserted-by":"crossref","unstructured":"Mohn AR, Gainetdinov RR, Caron MG, Koller BH: Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999; 98:427\u2013436","DOI":"10.1016\/S0092-8674(00)81972-8"},{"key":"R1577BABDBAEB","unstructured":"Meador-Woodruff JH, Ibrahim HM, Richardson-Burns SM, Hogg AJ Jr, Haroutunian V, Davis KL, Watson SJ Jr: Neurochemical anatomy of the thalamus in schizophrenia: glutamate-specific abnormalities. Schizophr Res 1999; 36:74"},{"key":"R1577BABFHHEG","unstructured":"Pearson BJ: Expression of the NR2B subunit of the NMDA receptor is increased in postmortem hippocampus of schizophrenics. Schizophr Res 1999; 36:75"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.157.7.1141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T01:07:05Z","timestamp":1722388025000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.157.7.1141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7,1]]},"references-count":70,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2000,7,1]]}},"alternative-id":["10.1176\/appi.ajp.157.7.1141"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.157.7.1141","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,7,1]]}}}